Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Michael Celano


  • Director at Orasure Technologies Inc (OSUR), 2019-05-22
  • Chief Operating Officer at Recro Pharma Inc. (REPH), 2019-02-19
  • Chief Financial Officer at Kensey Nash Corp (KNSY), 2012-06-26
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OSUR $14.95 44,962 Director 38,117 2017-05-05 Filing
OSUR $12.00 15,000 Director 83,079 2017-03-02 Filing
OSUR $10.06 10,000 Director 83,079 2017-02-09 Filing
OSUR $8.78 15,000 Director 93,079 2017-01-31 Filing